Latest filing published 02 Jul 2021 for Ensysce Biosciences, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
David Carl Humphrey is a declared insider at 2 companies (finance chief); the most frequent names are Senomyx Inc and Ensysce Biosciences, Inc. The record holds 3 filings, for trades running from 28 February 2018 to 30 June 2021.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 2 July 2021, reports a share grant in Ensysce Biosciences, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration